Page 11 - Joseph Wolk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Johnson & Johnson (JNJ) earnings Q4 2023

The results come six months after J&J completed its spinoff of consumer health unit Kenvue, the company's biggest shake-up in its nearly 140-year history.

Joseph wolkBoth imbruvicaInflation reductionBiotech and pharmaceuticalsHealth care industryJoe bidenKenvue incJohnson ampBreaking newsAbbvie incBusiness news

5 things to know before the stock market opens Tuesday

Here are the most important news items that investors need to start their trading day.

United statesSan diegoGus richardAnnika kim constantinoJoseph wolkAlex harringBrian priceLeslie josephsMonika bauerleinJonathan vanianAlaska airlinesUnited airlinesWall streetDow jones industrial averageNasdaq compositeCommonwealth financial

J&J Q4 Results: Profit edges past Street view after deals delay Stelara competition

Johnson & Johnson on Tuesday reported quarterly results just above Wall Street expectations, helped by strong sales of its blockbuster psoriasis drug Stelara, which is expected to face fresh U.S. competition from biosimilar versions next year.

United statesChris schottJoseph wolkJp morganDrug administrationWall streetFinancial officer joseph wolkJ ampj q4 earnings update

J&J may pay $700M to settle state AG probe into talcum powder marketing (NYSE:JNJ)

J&J may pay $700M to settle state AG probe into talcum powder marketing (NYSE:JNJ)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesNew mexicoJustin sullivanJoseph wolkWall street

J&J highlights Abiomed s first year in 2023 medtech earnings

J&J highlights Abiomed s first year in 2023 medtech earnings
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Johnson medtechJoaquin duatoAcuvue oasysBiosense websterJoseph wolkWall streetImpella connect